Company Number: OC444564

Analysis Date: 2025-07-20 13:20 UTC

Financial Health Assessment of PEGASUS I LLP

---

1. Financial Health Score: D

Explanation:
The financial data for PEGASUS I LLP reveals signs of financial distress, primarily due to persistent negative net current assets and shareholders' funds, which indicate undercapitalisation and liquidity challenges. The company's working capital position is unhealthy, signalling potential difficulties in meeting short-term liabilities. While the company is still active and compliant with filing deadlines, these financial symptoms suggest a fragile financial state requiring management attention.

---

2. Key Vital Signs (Critical Metrics and Interpretation)

Metric	2023 Value (£)	2021 Value (£)	Interpretation
Current Assets	2,543,892	483,825	Increased substantially, mainly due to stock growth, which could be a double-edged sword.
Cash	280,682	97,554	Cash reserves increased, but still low relative to current liabilities — liquidity concern.
Debtors	387,649	0	Debtors have appeared, reflecting sales on credit; requires monitoring for collectability risk.
Current Liabilities	3,173,522	483,918	Large increase, exceeding current assets and indicating potential cash flow strain.
Net Current Assets	-629,630	-93	Negative and worsening, indicating working capital deficiency—a symptom of financial distress.
Shareholders' Funds	-629,630	-93	Negative equity position, meaning liabilities exceed assets—sign of financial weakness.

Additional Notes:

• The significant stock increase from £386k to nearly £1.88m implies heavy investment in inventory (racehorses). This ties up cash and could create risk if stock is illiquid or overvalued.
• The negative net current assets (working capital) reflect an inability to cover short-term debts from current assets, a critical "vital sign" for liquidity health.
• Negative shareholders' funds show accumulated losses or capital deficiency, reducing the company's buffer against financial shocks.
• The company has no employees other than two members, which may limit overhead but also growth potential.

---

3. Diagnosis: What the Financial Data Reveals About Business Health

PEGASUS I LLP is displaying symptoms of financial distress, particularly liquidity risk and undercapitalisation. The large increase in current liabilities relative to current assets suggests the company may struggle to settle debts as they become due, creating a risk of operational disruption.

The company's stock-heavy asset base is a "locked-in" resource that may not convert quickly to cash, amplifying cash flow challenges. The negative equity position means the business has been operating at a loss or has withdrawn more than it has contributed, reducing financial resilience.

On the positive side, the company appears compliant with regulatory filing requirements and has increased cash reserves somewhat, which is a "healthy pulse" in terms of operational management. However, the "symptoms" (negative working capital, increasing liabilities) suggest the company should be cautious.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

a. Improve Liquidity and Cash Flow Management

• Accelerate debtor collections and tighten credit terms to improve cash inflows.
• Review stock levels and sell off non-core or slow-moving inventory to release cash.
• Negotiate with creditors for extended payment terms to ease short-term cash pressure.

b. Capital Structure and Funding

• Consider capital injection from members or external investors to restore positive equity and buffer losses.
• Explore short-term financing options like overdrafts or invoice factoring as a liquidity bridge.

c. Operational Efficiency

• Evaluate the business model's profitability, especially the racehorse trading activity, to ensure margins improve.
• Reduce unnecessary overheads and review all expense lines for potential savings.

d. Financial Monitoring and Reporting

• Implement regular cash flow forecasting to anticipate liquidity needs and prevent surprises.
• Maintain close monitoring of working capital components to detect early signs of distress.

---

Medical Analogy Summary

PEGASUS I LLP currently exhibits "symptoms" akin to a patient with a weakened cardiovascular system — its cash flow (the lifeblood) is constrained, and the "heart" (working capital) is under strain due to excess liabilities. Without intervention to restore liquidity and capital strength, the company risks "organ failure" in the form of insolvency or forced restructuring.

---